Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158812 | 0.89 | — | — | |
| SCHEMBL1132942 | 0.89 | — | — | |
| Ammonia Solution, Strong SCHEMBL1327720 | 0.87 | — | — | |
| SCHEMBL16765733 | 0.82 | — | — | |
| Succinic Acid SCHEMBL29509251 | 0.76 | POLB (0.50) | POLBL3MBTL1MEN1KMT2ADPP4 | |
| Biphenyl SCHEMBL7894663 | 0.73 | MEN1 (0.48) | POLBL3MBTL1MEN1KMT2A | |
| (Z)-1,2-Diphenylethene SCHEMBL20495486 | 0.70 | MEN1 (0.44) | MEN1KMT2A | |
| SCHEMBL571333 | 0.69 | — | — | |
| SCHEMBL6332843 | 0.69 | — | — | |
| SCHEMBL7614934 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270562-A1 | BIS-RNAI COMPOUNDS FOR CNS DELIVERY | BANK OF AMERICA, N.A. | 2025-08-28 | — | — | US | disclosed |
| WO-2024196898-A1 | CHEMICALLY MODIFIED NONCODING NUCLEOTIDES | CAMFORD LABS INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| WO-2024196893-A1 | CHEMICALLY MODIFIED NUCLEOTIDES | CAMFORD LABS INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| EP-4367237-A2 | BIS-RNAI COMPOUNDS FOR CNS DELIVERY | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| US-20230257745-A1 | Circular siRNAs | BANK OF AMERICA, N.A. | 2023-08-17 | — | — | US | disclosed |
| WO-2023283403-A2 | BIS-RNAI COMPOUNDS FOR CNS DELIVERY | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-01-12 | — | — | WO | disclosed |
| WO-2022011214-A1 | CIRCULAR SIRNAS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2022-01-13 | — | — | WO | disclosed |
| US-5714606-A | OLIGONUCLEOTIDE HAVING RECEPTOR BINDING SITES; ENZYME INHIBITORS, ANTIINFLAMMATORY AGENTS, MEDICAL DIAGNOSIS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| EP-0739335-A4 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS INC (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5574142-A | DRUG DELIVERY TO TARGET CELLS, ANTISENSE OLIGODEOXYNUCLEOTIDES | MICROPROBE CORPORATION (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0739335-A1 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| WO-1995018792-A1 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1995-07-13 | — | — | WO | disclosed |
| WO-1994013325-A9 | PEPTIDE LINKERS FOR IMPROVED OLIGONUCLEOTIDE DELIVERY | — | 1994-08-18 | — | — | WO | disclosed |
| WO-1994013325-A2 | PEPTIDE LINKERS FOR IMPROVED OLIGONUCLEOTIDE DELIVERY | MICROPROBE CORPORATION (US) | 1994-06-23 | — | — | WO | disclosed |